马洛替酯(malotilate)为近年投入临床使用的新型保肝药,一般认为其安全有效,毒副反应轻微,仅个别服药者有轻度的胃肠刺激症状及倦怠、嗜睡、一过性转氨酶升高等,不需停药,持续3-7d可自行消失。(国家“七五”重点科技攻关项目“214”工程资料汇编,1990;1:27-32)但我们最近发现1例用药引起全身过敏反应者,继续用药反应加剧而被迫停药,作者鲜见文献报道,兹简介如下。 In recent years, malotilate (malotilate) is a new type of hepatoprotective drug put into clinical use in recent years. It is generally considered to be safe and effective with mild side effects. Only a few individual patients have mild gastrointestinal irritation, fatigue, lethargy, transient transaminase Rise, etc., without stopping, sustained 3-7d disappear on their own. (National “Seventh Five-Year” key scientific and technological project “214” project data compilation, 1990; 1: 27-32) But we recently found that one case of systemic allergic reactions caused by medication, continued drug reactions and forced withdrawal, the author of fresh See the literature, it is briefed as follows.